Novartis (Sweden)-ko ikertzaileekin lankidetzan egindako argitalpenak (1)

2020

  1. Preclinical evaluation of the simultaneous inhibition of MCL-1 and BCL-2 with the combination of S63845 and venetoclax in multiple myeloma

    Haematologica